Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
424studies shown
Showing 1-12 of 424
Drug study icon
RecruitingNCT07263022

Cognitive Strategies in Early Psychosis 2

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Depression, ...DrugA study involving a medication or substance.From 18 Years to 35 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia, Depression, ...
Other study type icon
RecruitingNCT06740383

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Hartford
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 40 Years
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Condition
Schizophrenia, Bipolarity
Drug study icon
RecruitingISRCTN59554792

The efficacy of xanomeline-trospium in treating cognitive impairment in people with a psychotic disorder

This study is testing a medication approach for people with Schizophrenia, schizoaffective disorder, or schizophreniform disorder or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Schizophrenia
Device study icon
RecruitingNCT06907420

40 Hz Visual Stimulation as an Intervention in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Munich
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
Germany
Sponsor
Technical University of Munich
Condition
Schizophrenia
Device study icon
RecruitingNCT06107764

Cerebellar Modulation of Cognition in Psychosis

This study is looking at whether a digital support tool can help people with Schizophrenia, schizoaffective disorder, bipolarity I, or Psychosis. Participants take part in a digital support tool and complete follow-up assessments.

Multiple locations, including Belmont
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDeviceFrom 18 Years to 55 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Schizophrenia, Bipolarity
Behavioral study icon
RecruitingNCT06071858

Enhanced Coordinated Specialty Care for Early Psychosis

This study is looking at whether Care Coordination can help people with psychosis or bipolarity. Participants take part in Care Coordination and complete follow-up assessments.

Multiple locations, including Belmont
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityBehavioral
Countries
United States
Sponsor
Mclean Hospital
Condition
Schizophrenia, Bipolarity
Drug study icon
RecruitingNCT05511363

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in the United Kingdom, ...

Multiple locations, including Orange
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Drug study icon
RecruitingNCT06126224

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Canada, in the United Kingdom, ...

Multiple locations, including Stuart
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, Canada, United Kingdom, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.